| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Vaxart (NASDAQ:VXRT) is set to give its latest quarterly earnings report on Wednesday, 2025-08-13. Here's what investors need to know before the announcement.
Analysts estimate that Vaxart will report an earnings per share (EPS) of $-0.10.
The announcement from Vaxart is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
The company's EPS missed by $0.00 in the last quarter, leading to a 3.73% drop in the share price on the following day.
Here's a look at Vaxart's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.11 | -0.10 | -0.03 |
| EPS Actual | -0.07 | -0.04 | -0.06 | -0.09 |
| Price Change % | -4.0% | -9.0% | -12.0% | -8.0% |
Shares of Vaxart were trading at $0.32 as of August 11. Over the last 52-week period, shares are down 38.04%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for Vaxart visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: VXRT
